Suppressor of cytokine signaling 2 (Socs2) deletion protects bone health of mice with DSS-induced inflammatory bowel disease
Individuals with inflammatory bowel disease (IBD) often present with poor bone health. The development of targeted therapies for this bone loss requires a fuller understanding of the underlying cellular mechanisms. Although bone loss in IBD is multifactorial, the altered sensitivity and secretion of...
Main Authors: | Ross Dobie, Vicky E. MacRae, Chloe Pass, Elspeth M. Milne, S. Faisal Ahmed, Colin Farquharson |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2018-01-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/11/1/dmm028456 |
Similar Items
-
Nutritional and dietary strategy in the clinical care of inflammatory bowel disease
by: Meng-Shu Hsieh, et al.
Published: (2020-12-01) -
Inflammatory bowel diseases and primary immunodeficiency diseases
by: Hirokazu Kanegane
Published: (2019-01-01) -
Risk of Prevalent Asthma among Children Affected by Inflammatory Bowel Disease: A Population-Based Birth Cohort Study
by: Claudio Barbiellini Amidei, et al.
Published: (2020-06-01) -
Inflammatory Bowel Disease: Genetics, Epigenetics and Pathogenesis
by: Italia eLoddo, et al.
Published: (2015-11-01) -
A Step Forward in the Understanding of Structural and Functional Bowel Damage in Patients with Ulcerative Colitis
by: Catarina Gouveia, et al.
Published: (2017-11-01)